{"id":"NCT01191268","sponsor":"Eli Lilly and Company","briefTitle":"A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)","officialTitle":"The Impact of LY2189265 Versus Insulin Glargine in Combination With Insulin Lispro for the Treatment to Target of Type 2 Diabetes Mellitus (AWARD-4: Assessment of Weekly AdministRation of LY2189265 in Diabetes - 4)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-11","primaryCompletion":"2012-02","completion":"2012-09","firstPosted":"2010-08-30","resultsPosted":"2014-10-08","lastUpdate":"2014-10-08"},"enrollment":884,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Insulin Glargine","otherNames":[]},{"type":"DRUG","name":"LY2189265","otherNames":["Dulaglutide"]},{"type":"DRUG","name":"Insulin Lispro","otherNames":[]}],"arms":[{"label":"1.5 mg LY2189265","type":"EXPERIMENTAL"},{"label":"0.75 mg LY2189265","type":"EXPERIMENTAL"},{"label":"Insulin Glargine","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy and safety of LY2189265 in comparison to Insulin Glargine, both in combination with Insulin Lispro (plus or minus Metformin), in participants with Type 2 Diabetes treated with 1 or 2 injections of insulin.","primaryOutcome":{"measure":"Change From Baseline to 26-week Endpoint in Glycosylated Hemoglobin (HbA1c)","timeFrame":"Baseline, 26 weeks","effectByArm":[{"arm":"1.5 mg LY2189265","deltaMin":-1.64,"sd":0.07},{"arm":"0.75 mg LY2189265","deltaMin":-1.59,"sd":0.07},{"arm":"Insulin Glargine","deltaMin":-1.41,"sd":0.07}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG002","p":"0.005"},{"comp":"OG001 vs OG002","p":"0.015"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":17},"locations":{"siteCount":101,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","Denmark","Greece","Hungary","Mexico","Poland","Puerto Rico","Russia","Spain","Sweden","Taiwan"]},"refs":{"pmids":["29430801","27161178","26691396","26009229"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":27,"n":295},"commonTop":["Nausea","Diarrhea","Common cold","Vomiting","Nasopharyngitis"]}}